High-Purity CTC RNA Sequencing Identifies Prostate Cancer Lineage Phenotypes Prognostic for Clinical OutcomesMarina N. Sharifi, Joshua M. Lang, Jamie M. Sperger et al.|Cancer Discovery|2025Cited by 16
Analysis of cfDNA fragmentomics metrics and commercial targeted sequencing panelsKyle T. Helzer, Shuang G. Zhao, Marina N. Sharifi et al.|Nature Communications|2025Cited by 9
Circulating tumor cell (CTC) expression patterns of cell surface targets in metastatic prostate cancer.Kendra D. Marr, Marina N. Sharifi, Jamie M. Sperger et al.|Journal of Clinical Oncology|2025Cited by 1
Abstract 3696: Liquid biopsy biomarker analysis during treatment with 177Lu-PSMA-617 in castrate resistant prostate cancerJamie M. Sperger, Joshua M. Lang, Marina N. Sharifi et al.|Cancer Research|2024Cited by 1
Fragmentomics of cell-free DNA from targeted panels in genitourinary malignancies.Amy K. Taylor, Shuang G. Zhao, Alexander W. Wyatt et al.|Journal of Clinical Oncology|2024Cited by 1